Published in the Journal of Ethnopharmacology in 2014, researchers conducted a meta-analysis of randomized controlled trials testing Bacopa monnieri extract on cognitive function. They identified 9 studies meeting inclusion criteria with 518 total subjects.

The analysis found that Bacopa significantly improved speed of attention. Choice reaction time - how fast someone picks the correct response from multiple options - improved by 10.6 milliseconds. Trail Making Test B completion time - which measures how quickly someone can switch between different mental tasks - improved by 17.9 milliseconds. Both results were highly statistically significant.

All included trials had low risk of bias and high quality of reported information. The authors noted that Bacopa has been used in traditional Indian medicine for centuries and concluded it has genuine potential to improve cognitive processing speed, though they called for larger head-to-head trials against existing medications.

Published in Frontiers in Nutrition in 2024, researchers conducted a systematic review and meta-analysis of randomized controlled trials published between 1993 and 2024 examining creatine supplementation and cognitive function. They analyzed 16 RCTs involving 492 participants aged 20.8 to 76.4 years.

Creatine is naturally produced in the body and also found in meat and fish. The brain uses about 20% of the body's energy, and creatine helps regenerate the energy molecule ATP in brain cells. Supplementation at typical doses of 5 to 20 grams per day for periods ranging from 5 days to 6 weeks was tested across the studies.

The meta-analysis found statistically significant positive effects on memory tasks and attention response time. The benefits appeared most consistent in people under stress conditions such as sleep deprivation, and in vegetarians whose baseline creatine levels are lower due to diet. The authors concluded creatine supplementation shows promise as a cognitive enhancer, particularly under demanding conditions.

Published in European Neuropsychopharmacology in 2015, researchers at Oxford University conducted a systematic review of 24 studies examining modafinil use in healthy people who were not sleep-deprived. This was the first comprehensive review of the drug as a cognitive enhancer in well-rested individuals.

The review found that modafinil consistently improved performance on complex cognitive tasks. Decision-making and planning abilities showed the most reliable enhancement. The longer and more complex the task, the more consistently modafinil provided benefits. Simple tasks showed little or no improvement.

Modafinil did not significantly affect working memory or flexibility of thought. The review also found no serious side effects or mood changes at standard doses. The authors concluded that modafinil can be considered a cognitive enhancer, at least for certain types of thinking that require sustained attention and executive function.

Published in 2025, a systematic review and meta-analysis examined all randomized, placebo-controlled clinical trials on L-theanine and cognitive performance. L-theanine is an amino acid found naturally in tea leaves.

Across the included trials, L-theanine at doses of 100 to 400 mg significantly improved reaction times on attention tasks compared to placebo. Working memory accuracy also improved, with participants making more correct responses and fewer omission errors. A double-blind crossover study found that 400 mg produced measurable changes in brain electrical activity (larger P3b wave amplitudes), indicating deeper attentional processing of information.

When combined with caffeine, L-theanine improved visual color discrimination reaction time by about 27 milliseconds compared to placebo. The combination appeared to provide benefits beyond either substance alone, suggesting synergistic effects. The authors noted that while results are promising, the overall evidence base still needs larger long-term trials.

Published in Nutrients in 2023, researchers at the University of Queensland conducted a randomized, double-blind, parallel-groups pilot study with 41 healthy adults aged 18 to 45. Participants received either 1.8 grams of Hericium erinaceus (lion''s mane mushroom) or placebo daily for 28 days.

After a single dose, participants in the lion''s mane group performed significantly faster on the Stroop task - a test that measures the ability to process conflicting information and resist interference. The improvement was measurable at just 60 minutes after taking the supplement. A trend toward reduced subjective stress was also observed after the full 28-day supplementation period.

Lion''s mane contains compounds called hericenones and erinacines that stimulate nerve growth factor production in the brain. The authors described this as a pilot study and noted the sample was small, but the acute cognitive effects were statistically significant and consistent with the proposed biological mechanism.

Published in Scientific Reports in 2025, researchers conducted a systematic review and dose-response meta-analysis of randomized controlled trials examining omega-3 supplementation and cognitive function across adult populations.

The meta-analysis found that omega-3 supplementation produced a small but statistically significant positive effect on overall cognitive performance. The type of omega-3 mattered: EPA (eicosapentaenoic acid) appeared more effective for cognitive outcomes in some analyses than DHA (docosahexaenoic acid) alone. A separate 2022 study specifically found that EPA-rich supplementation improved global cognitive function in healthy young adults.

The dose-response analysis showed that very low doses were ineffective, with a threshold below which no benefits appeared. The authors noted that baseline omega-3 status likely influences whether supplementation helps - people with low dietary intake of fish and seafood may benefit more than those already consuming adequate amounts.

Published in Scientific Reports in 2024, researchers tested whether a single large dose of creatine (0.35 grams per kilogram of body weight) could counteract the cognitive decline caused by sleep deprivation. The study used phosphorus magnetic resonance spectroscopy to directly measure energy molecule levels in the brain.

After taking creatine, participants who had been awake for an extended period showed significantly better performance on cognitive tasks compared to placebo. Brain scans confirmed that creatine supplementation increased phosphocreatine levels in the brain - the energy reserve that neurons use during demanding mental work.

The study demonstrated a direct biological mechanism: creatine enters the brain, increases the available energy supply for neurons, and this translates into measurable cognitive improvement. The authors noted this was the first study to show both the brain energy change and cognitive improvement simultaneously from a single dose, providing strong mechanistic evidence for how creatine enhances cognition.

Published in Frontiers in Nutrition in 2022, researchers conducted a randomized, triple-blinded (participant, researcher, and statistician all blinded), placebo-controlled crossover trial examining a multi-ingredient dietary nootropic in healthy young adults.

The supplement contained a combination of ingredients commonly marketed as cognitive enhancers. After acute consumption, participants showed significantly improved reaction times across different cognitive tests, improved accuracy on attention and memory tasks, and higher scores on a creativity assessment. Self-reported positive emotions also increased compared to the placebo condition.

The effect sizes were medium, meaning the improvements were noticeable and practically relevant, not just statistically detectable. The crossover design - where each participant served as their own control - strengthens the findings by eliminating individual differences as a confounding factor. The triple-blinding was particularly rigorous, reducing the possibility that expectations influenced results.

Published in 2024, a double-blind, placebo-controlled study examined the acute cognitive effects of alpha-GPC (alpha-glycerylphosphorylcholine) supplementation in healthy young men. Alpha-GPC is a choline compound that crosses the blood-brain barrier and increases acetylcholine levels - a neurotransmitter critical for memory and attention.

Participants received either a high dose (600 mg), a low dose (200 mg), or placebo. Both supplement groups showed significantly improved cognitive performance compared to placebo as measured by changes in the Stroop Total Score and task completion time. The Stroop test measures the ability to focus attention, process information quickly, and suppress automatic responses.

The results suggest that alpha-GPC can acutely enhance cognitive processing even in young, healthy individuals who have no cognitive impairment. The researchers attributed the effect to increased cholinergic neurotransmission - essentially providing the brain with more raw material to produce the neurotransmitter acetylcholine.

Published in Frontiers in Pharmacology in 2025, researchers conducted a network meta-analysis - a statistical method that simultaneously compares multiple treatments against each other and against placebo - examining natural extracts used for cognitive enhancement in healthy adults.

The analysis included randomized controlled trials of various plant-derived nootropic compounds. Among the interventions analyzed, certain extracts showed statistically significant advantages over placebo on specific cognitive domains. Bacopa monnieri consistently improved attention speed, while sage and ginseng extracts showed benefits in memory and executive function tasks.

The network meta-analysis format allowed the researchers to rank the effectiveness of different natural nootropics against each other, not just against placebo. This provided a clearer picture of which supplements have the strongest evidence base. The authors noted that while individual effects are modest, the consistency across multiple independent trials supports genuine cognitive-enhancing properties for select plant compounds.